Techcyte unveils Fusion, the first unified anatomic and clinical digital pathology platform

Techcyte, a leader in AI-powered digital pathology, announced the launch of Fusion, the first open, standards-based, SaaS platform designed to unify anatomic and clinical pathology workflows. By bringing  together pathology teams, IT systems, and AI into a single, integrated platform, Fusion aims to eliminate workflow silos, enhance diagnostic accuracy, and improve interoperability, setting a new industry standard for digital pathology.

Developed in collaboration with experienced digital pathologists, Fusion represents the next generation of  digital pathology, where stakeholders work together on a unified platform, and AI-powered tools are  seamlessly embedded into clinical practice to optimize efficiency, collaboration, and patient outcomes.

A Unified, AI-Powered Pathology Workflow

Pathologists today face the challenge of navigating multiple disconnected systems, fragmented data  sources, and manual workflows, all of which slow down efficiency and decision-making. Fusion eliminates  these inefficiencies by seamlessly integrating patient data, whole slide imaging, laboratory information  systems (LIS), communication tools, and AI-powered diagnostics, enabling pathologists to make faster,  more informed diagnoses.

“We have successfully delivered over 5,000,000 clinical AI diagnoses to veterinary,  environmental, and clinical pathology. By adding anatomic pathology to Fusion, weʼre  shaping what it means to have a complete, unified digital pathology platform. Fusion’s  strength lies in uniting pathology practice stakeholders within a singular, AI-driven,  workflow-first platform to improve efficiency and positively impact patient care,ˮ

said Ben Cahoon, CEO of Techcyte.

An Open, Standards-Based Platform

Designed as a cloud-native SaaS solution, Fusion is built on industry standards, including DICOM, FHIR,  HL7, and DICOMWeb, ensuring seamless integration with the LIS, EHR, slide scanners, and image  management systems such as VNAs. Its open architecture enables laboratories to incorporate third-party  AI, alongside Techcyteʼs proprietary AI, unlocking new diagnostic insights and enhancing workflow  efficiency.

“Pathology is going digital, but adoption has been hampered by proprietary systems,  limited use of standards, and an insufficient focus on workflow. Fusion is fully committed  to using standards to ensure customers have long-term, durable, portable data and  systems,ˮ

said Tiffany Chen, Chief Medical Officer at Techcyte.

Delivering on the Promise of Digital Pathology

Digital pathology offers the potential to revolutionize diagnostic efficiency and accuracy, but achieving  these benefits requires seamless AI integration within clinical workflows. Techcyte’s Fusion platform  realizes this vision by uniting AI, pathologists, and technology into a streamlined system. Through in-house innovation and partnerships with AI vendors, Fusion empowers labs with tools that have the potential to  enhance efficiency, improve accuracy, and elevate diagnostic confidence. Fusion ensures AI is a core  component of the diagnostic process, finally delivering on the long-promised potential of digital pathology.

About Techcyte

Founded in 2013, Techcyte is transforming the practice of pathology with a unified pathology platform that digitizes lab workflows and offers AI tools that aim to improve the efficiency and accuracy of diagnostic  testing.

Our mission is to positively impact the health of humans, animals, and the environment through the use of  artificial intelligence.

We do this by partnering with best-in-class labs, whole slide scanner manufacturers, AI vendors, diagnostic companies, hardware manufacturers, and solution providers. Together, we aim to deliver a unified  anatomic and clinical pathology platform to labs and clinics around the world.

Techcyteʼs anatomic and clinical pathology platform is for Research Use Only in the United States.